MK-7075: payments to doctors
Payments that named MK-7075 as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Merck?
Merck reported the most payments naming MK-7075. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $18K
- Providers
- 10
- Transactions
- 28
- Average per transaction
- $646
The per-transaction average — $646 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10 providers the average total is $1,808, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Merck | $18,078 | 100.0% |
Other products from Merck
The company that reported the most payments naming MK-7075 also reports against these.